Climb Bio, Inc.(NasdaqGM: CLYM) dropped from Russell 2000 Index - MarketScreener
2 days ago • Google News
Climb Bio Inc (CLYM)
US$ 3.797.67%
Price Chart
Key Statistics
Market Cap
$ 85.82M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
387.87K
52W High
$ 9.21
52W Low
$ 1.05
Dividend Yield
0.00%
Beta
-0.11
Technicals
50-Day MA
1.2639
200-Day MA
3.2915
52 Week High
9.21
52 Week Low
1.05
About CLYM
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.
Employees
17
Headquarters
Wellesley Hills, MA
CEO
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg